Millendo Therapeutics, Inc. (MLND) financial statements (2021 and earlier)

Company profile

Business Address 110 MILLER AVENUE, SUITE 100
ANN ARBOR, MI 48104
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3964786711412760
Cash and cash equivalents3862731644436
Short-term investments   52708354
Other undisclosed cash, cash equivalents, and short-term investments114(0)00(0)
Restricted cash and investments010  0 
Receivables012    
Deferred costs      0
Assets held-for-sale, not part of disposal group   0  
Other undisclosed current assets1531232
Total current assets:4171836911613062
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment   3683
Long-term investments and receivables   00  
Long-term investments   00  
Restricted cash and investments  01000
Other noncurrent assets01000 0
Total noncurrent assets:3414694
TOTAL ASSETS:4375847312313966
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities711108131113
Accounts payable1122233
Accrued liabilities69861188
Employee-related liabilities      3
Debt020    
Other undisclosed current liabilities1     (3)
Total current liabilities:813108131110
Noncurrent Liabilities
Long-term debt and lease obligation230    
Long-term debt, excluding current maturities000    
Operating lease, liability22
Liabilities, other than long-term debt 011110
Other liabilities 011110
Other undisclosed noncurrent liabilities(2)      
Total noncurrent liabilities:2311110
Total liabilities:1015119141210
Stockholders' equity
Stockholders' equity attributable to parent3359716410812755
Common stock0000000
Additional paid in capital278267235366358295150
Accumulated other comprehensive income (loss)000(0)(0)(0)(0)
Accumulated deficit(245)(209)(164)(301)(250)(168)(95)
Stockholders' equity attributable to noncontrolling interest112    
Total stockholders' equity:3460736410812755
TOTAL LIABILITIES AND EQUITY:4375847312313966

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues00 010 
Sublease income00
Cost of revenue   (1)(5)(2) 
Gross profit:00 (0)(5)(2) 
Operating expenses(36)(45)(27)(51)(82)(72)(48)
Other undisclosed operating income (loss)(0)(0) 152 
Operating loss:(36)(45)(27)(51)(81)(72)(48)
Nonoperating income (expense)(1)(0) 100(0)
Investment income, nonoperating(1)(0) 110(0)
Other nonoperating income (expense)   (0)(0)(0)0
Interest and debt expense  (0)    
Loss from continuing operations before equity method investments, income taxes:(37)(46)(27)(50)(81)(72)(48)
Loss from equity method investments   (1)(2)(2)(2)
Loss from continuing operations before income taxes:(37)(46)(27)(51)(82)(73)(50)
Income tax expense   (0)(0)(0) 
Loss before gain (loss) on sale of properties:(37)(46)(27)(51)(82)(73)(50)
Other undisclosed net income (loss)01(0)    
Net loss:(36)(45)(27)(51)(82)(73)(50)
Net loss attributable to noncontrolling interest  (0)    
Net loss available to common stockholders, diluted:(36)(45)(27)(51)(82)(73)(50)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(36)(45)(27)(51)(82)(73)(50)
Other undisclosed comprehensive income  051827349
Comprehensive income (loss):(36)(45)(27)00(0)(0)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (0)    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00 (51)(82)(73)(50)
Comprehensive loss, net of tax, attributable to parent:(36)(45)(27)(51)(82)(73)(50)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: